Trial Profile
A Phase 2 Study of Abemaciclib in Combination With Letrozole or in Combination With Letrozole and Metformin in Recurrent or Persistent Endometrial Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Mar 2023
Price :
$35
*
At a glance
- Drugs Abemaciclib (Primary) ; Letrozole (Primary) ; Metformin (Primary) ; Samotolisib (Primary)
- Indications Adenocarcinoma; Endometrial cancer
- Focus Therapeutic Use
- 21 Mar 2023 Planned number of patients changed from 40 to 60.
- 21 Mar 2023 Planned End Date changed from 1 May 2025 to 1 May 2026.
- 21 Mar 2023 Planned primary completion date changed from 1 May 2023 to 1 May 2024.